1.38

3.50% -0.05

Autolus Therapeutics Plc Adr (AUTL)

Overview News Price History Option Chain Financials Discussions Forecast

Autolus Therapeutics Plc Adr stock is traded at $1.38, with a volume of 1.04M. It is down -3.50% in the last 24 hours and down -8.00% over the past month. Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.

Previous Close:

$1.43

Open:

$1.43

24h Volume:

1.04M

Relative Volume:

0.38

Market Cap:

$367.28M

Revenue:

$51.25M

Net Income/Loss:

$-224.64M

P/E Ratio:

-1.6349

EPS:

-0.8441

Net Cash Flow:

$-306.93M

1W Performance:

+4.55%

1M Performance:

-8.00%

6M Performance:

-35.96%

1Y Performance:

-29.59%

1-Day Range:

$1.3645

$1.44

1-Week Range:

$1.33

$1.48

52-Week Range:

$1.105

$2.70

Autolus Therapeutics Plc Adr Stock (AUTL) Company Profile

Name

Autolus Therapeutics Plc Adr

Sector

Healthcare (1112)

Industry

Biotechnology (621)

Phone

44 20 3829 6230

Address

THE MEDIAWORKS, LONDON

Employee

647

Twitter

Next Earnings Date

2024-12-12

Latest SEC Filings

AUTL's Discussions on Twitter

Compare AUTL vs VRTX, REGN, ARGX, ALNY, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
AUTL Autolus Therapeutics Plc Adr	1.38	380.58M	51.25M	-224.64M	-306.93M	-0.8441
VRTX Vertex Pharmaceuticals Inc	465.02	117.03B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	783.65	82.35B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	833.54	51.64B	3.06B	1.28B	447.35M	19.67
ALNY Alnylam Pharmaceuticals Inc	308.48	42.58B	3.21B	43.57M	221.36M	0.2405
ONC Beone Medicines Ltd Adr	346.42	38.87B	4.98B	69.60M	525.67M	0.5198

Autolus Therapeutics Plc Adr Stock (AUTL) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-18-24	Upgrade	Goldman	Neutral → Buy
Nov-15-24	Upgrade	Redburn Atlantic	Neutral → Buy
Nov-09-23	Initiated	Deutsche Bank	Buy
Mar-27-23	Resumed	Wells Fargo	Overweight
Mar-17-23	Initiated	Bryan Garnier	Buy
Jun-14-21	Upgrade	Jefferies	Hold → Buy
Jan-29-21	Downgrade	JP Morgan	Overweight → Neutral
Dec-28-20	Resumed	H.C. Wainwright	Buy
Jul-31-20	Initiated	JP Morgan	Overweight
Jul-22-20	Initiated	SunTrust	Buy
Apr-22-20	Initiated	Mizuho	Buy
Sep-23-19	Initiated	Needham	Buy
May-17-19	Reiterated	H.C. Wainwright	Buy
Oct-24-18	Initiated	H.C. Wainwright	Buy

View All

Autolus Therapeutics Plc Adr Stock (AUTL) Latest News

Feb 07, 2026

Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL) Given Average Recommendation of "Hold" by Brokerages - MarketBeat

Feb 07, 2026

Jan 30, 2026

New Strong Sell Stocks for January 30th - Yahoo Finance

Jan 30, 2026

Jan 24, 2026

Autolus Therapeutics (NASDAQ:AUTL) Cut to Strong Sell at Zacks Research - Defense World

Jan 24, 2026

Jan 22, 2026

New Strong Sell Stocks for January 22nd - Yahoo! Finance Canada

Jan 22, 2026

Jan 13, 2026

Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL) Given Consensus Rating of “Moderate Buy” by Brokerages - Defense World

Jan 13, 2026

Silver Viper Minerals (CVE:VIPR) Trading Down 15.3% – Here’s What Happened - Defense World

Jan 13, 2026

Jan 07, 2026

Free cash flow per share of Autolus Therapeutics Plc Sponsored ADR – FWB:6A3A - TradingView — Track All Markets

Jan 07, 2026

Dec 30, 2025

Autolus Therapeutics (NASDAQ:AUTL) Price Target Raised to $11.00 at Needham & Company LLC - Defense World

Dec 30, 2025

Autolus Therapeutics (NASDAQ:AUTL) Trading Up 13.5% Following Analyst Upgrade - Defense World

Dec 30, 2025

Dec 29, 2025

Autolus Therapeutics stock jumps after Needham raises price target By Investing.com - Investing.com South Africa

Dec 29, 2025

Needham raises Autolus Therapeutics stock price target on Aucatzyl launch success - Investing.com

Dec 29, 2025

Dec 27, 2025

Is Autolus Therapeutics plc (AUTL) The Best Get Rich Fast Stocks to Buy Right Now? - Finviz

Dec 27, 2025

Dec 22, 2025

Perpetual Ltd Has $784,000 Position in Autolus Therapeutics PLC Sponsored ADR $AUTL - Defense World

Dec 22, 2025

Dec 19, 2025

Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL) Receives Average Rating of “Moderate Buy” from Analysts - Defense World

Dec 19, 2025

Dec 15, 2025

The i-80 Gold Corp (IAUX) had a good session last reading, didn’t it? - uspostnews.com

Dec 15, 2025

Autolus Therapeutics’ (AUTL) “Buy” Rating Reiterated at Needham & Company LLC - Defense World

Dec 15, 2025

Dec 09, 2025

Views of Wall Street’s Leading Experts on Autolus Therapeutics plc ADR - setenews.com

Dec 09, 2025

Wall Street analysts’ outlook for AlphaVest Acquisition Corp (ATMV) - setenews.com

Dec 09, 2025

Dec 02, 2025

Check Out Autolus Therapeutics plc ADR (AUTL)’s Trade Data Rather Than the Analysts’ Views - Setenews

Dec 02, 2025

Cetera Investment Advisers Has $1.41 Million Position in Autolus Therapeutics PLC Sponsored ADR $AUTL - Defense World

Dec 02, 2025

Dec 01, 2025

Ryan Richardson joins Autolus Therapeutics board of directors - Investing.com

Dec 01, 2025

Nov 25, 2025

An analyst sees good growth prospects for Autolus Therapeutics plc ADR (AUTL) - Setenews

Nov 25, 2025

Taking on analysts’ expectations and winning: EON Resources Inc (EONR) - Setenews

Nov 25, 2025

Ready to Jump After Recent Trade: BitMine Immersion Technologies Inc (BMNR) - Setenews

Nov 25, 2025

Iterum Therapeutics Plc (ITRM) Performance and Fundamentals Dashboard tells a completely different story - Setenews

Nov 25, 2025

Taking on analysts’ expectations and winning: enVVeno Medical Corporation (NVNO) - Setenews

Nov 25, 2025

Check out these key findings about Streamex Corp (STEX) - Setenews

Nov 25, 2025

This trade activity should not be overlooked: ETHZilla Corp (ETHZ) - Setenews

Nov 25, 2025

A better buy-in window may exist right now for Centessa Pharmaceuticals plc ADR (CNTA) - Setenews

Nov 25, 2025

How does Advanced Biomed Inc (ADVB) change from a tortoise to a hare? - Setenews

Nov 25, 2025

A look into Mobile health Network Solutions (MNDR)’s deeper side - Setenews

Nov 25, 2025

Traws Pharma Inc (TRAW) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - Setenews

Nov 25, 2025

Taking on analysts’ expectations and winning: Gelteq Ltd (GELS) - Setenews

Nov 25, 2025

Wall Street analysts’ outlook for Amaze Holdings Inc (AMZE) - Setenews

Nov 25, 2025

Is Autolus Therapeutics PLC (AUTL) One of the Fastest-Growing Penny Stocks to Buy Now? - Finviz

Nov 25, 2025

NICE Recommends AUCATZYL® (obecabtagene autoleucel) as a Treatment Option for Adult Patients (≥26 years) with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (R/R B-ALL)¹ - GlobeNewswire Inc.

Nov 25, 2025

Autolus Therapeutics Surges: What’s Next for the Stock? - StocksToTrade

Nov 25, 2025

Nov 24, 2025

ADC Therapeutics SA (NYSE:ADCT) Receives Average Rating of “Moderate Buy” from Analysts - Defense World

Nov 24, 2025

Nov 21, 2025

A new trading data show Ashford Hospitality Trust Inc (AHT) is showing positive returns. - Setenews

Nov 21, 2025

Taking on analysts’ expectations and winning: Houston American Energy Corp (HUSA) - Setenews

Nov 21, 2025

Does Klotho Neurosciences Inc (KLTO) offer a good opportunity for investors? - Setenews

Nov 21, 2025

The time has not yet come to remove your chips from the table: Psyence Biomedical Ltd (PBM) - Setenews

Nov 21, 2025

Nov 20, 2025

Newsmax Inc (NMAX) can make a big difference with a little luck - Setenews

Nov 20, 2025

Check Out Dolly Varden Silver Corp (DVS)’s Trade Data Rather Than the Analysts’ Views - Setenews

Nov 20, 2025

Views of Wall Street’s Leading Experts on Viomi Technology Co Ltd ADR - Setenews

Nov 20, 2025

Nov 19, 2025

Are Smart Investors Making the Right Decision? Empery Digital Inc (EMPD) - Setenews

Nov 19, 2025

Wall Street analysts’ outlook for Picard Medical Inc (PMI) - Setenews

Nov 19, 2025

Nov 18, 2025